These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6271094)

  • 41. The effect of 2,3-dihydroxybenzoic acid and tempol in prevention of vancomycin-induced nephrotoxicity in rats.
    Naghibi B; Ghafghazi T; Hajhashemi V; Talebi A; Taheri D
    Toxicology; 2007 Apr; 232(3):192-9. PubMed ID: 17296255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Studies on the mechanisms of renal damages induced by nephrotoxic compounds].
    Yamada T
    Nihon Hoigaku Zasshi; 1995 Dec; 49(6):447-57. PubMed ID: 8583688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of drug-metabolizing enzyme inducers on cephaloridine toxicity in Fischer 344 rats.
    Kuo CH; Hook JB
    Toxicology; 1982; 24(3-4):293-303. PubMed ID: 6100830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative studies on nephrotoxic effects of tris (2,3-dibromopropyl) phosphate and bis (2,3-dibromopropyl) phosphate on rat urinary metabolites.
    Fukuoka M; Takahashi T; Naito K; Takada K
    J Appl Toxicol; 1988 Feb; 8(1):43-52. PubMed ID: 3356864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relieving effect of saline on cephaloridine nephrotoxicity in rats.
    Hayashi T; Sudo J
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):785-90. PubMed ID: 2752494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats.
    Liu J; Habeebu SS; Liu Y; Klaassen CD
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):48-58. PubMed ID: 9875299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A study of the nephrotoxicity of three cephalosporins in rabbits using 1H NMR spectroscopy.
    Halligan S; Byard SJ; Spencer AJ; Gray TJ; Harpur ES; Bonner FW
    Toxicol Lett; 1995 Nov; 81(1):15-21. PubMed ID: 8525494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reductions in renal mass and the nephropathy induced by mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):366-79. PubMed ID: 9144453
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of cephalosporins on organic ion transport in renal membrane vesicles from rat and rabbit kidney cortex.
    Williams PD; Hitchcock MJ; Hottendorf GH
    Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):357-71. PubMed ID: 2986254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclosporine and renal enzyme excretion.
    Whiting PH; Thomson AW; Simpson JG
    Clin Nephrol; 1986; 25 Suppl 1():S100-4. PubMed ID: 2871955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cephalosporin nephrotoxicity. Transport, cytotoxicity and mitochondrial toxicity of cephaloglycin.
    Tune BM; Fravert D
    J Pharmacol Exp Ther; 1980 Oct; 215(1):186-90. PubMed ID: 7452482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of aminoglycosides and cephaloridine in the rabbit kidney.
    Dolislager D; Fravert D; Tune BM
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):13-23. PubMed ID: 515499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Kidney lesion in mice from an antirenal serum].
    Averkina RF
    Arkh Patol; 1975; 37(7):56-61. PubMed ID: 1182048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enzyme histochemistry of rat folic acid nephropathy.
    Pataki A; Meier-Ruge W; Sandoz P; wiederhold KH
    Beitr Pathol; 1977 Apr; 160(1):82-92. PubMed ID: 193486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of renal enzymuria and cellular excretion as an marker of acute nephrotoxicity due to an overdose of paracetamol in Wistar rats.
    da Silva Melo DA; Saciura VC; Poloni JA; Oliveira CS; Filho JC; Padilha RZ; Reichel CL; Neto EJ; Oliveira RM; D'avila LC; Kessler A; de Oliveira JR
    Clin Chim Acta; 2006 Nov; 373(1-2):88-91. PubMed ID: 16806140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients.
    Rouan MC; Binswanger U; Bammatter F; Theobald W; Schoeller JP; Guibert J
    J Antimicrob Chemother; 1984 Jun; 13(6):611-8. PubMed ID: 6088464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The nephrotoxic potential of gentamicin in the cat: enzymuria and alterations in urine concentrating capability.
    Hardy ML; Hsu RC; Short CR
    J Vet Pharmacol Ther; 1985 Dec; 8(4):382-92. PubMed ID: 4094028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of ochratoxin A on brush border enzymes of rat kidney.
    Pepeljnjak S; Cepelak I; Juretić D
    IARC Sci Publ; 1991; (115):273-7. PubMed ID: 1687921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathogenesis of nephrotoxicity of cephalosporins and aminoglycosides: a review of current concepts.
    Silverblatt F
    Rev Infect Dis; 1982; 4 Suppl():S360-5. PubMed ID: 7178755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of novel targets of cephaloridine in rabbit renal proximal tubules synthesizing glutamine from alanine.
    Guitton J; Conjard A; Eid A; Martin M; Boghossian M; Delage H; Baverel G; Ferrier B
    Arch Toxicol; 2005 Oct; 79(10):587-94. PubMed ID: 15991025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.